Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H Vlasses

Showing results (41-50 of 169) with videos related to

Pageof 17
Sort By:
Rational Drug Therapy|August 1, 1984
Amiodarone: a new drug for the treatment of cardiac arrhythmiasA J Greenspon, P H Vlasses, R K Ferguson
Clinical Nephrology|October 1, 1984
Creatinine serum concentrations and H2-receptor antagonistsM L Rocci, P H Vlasses, R K Ferguson
Clinical Pharmacy|November 1, 1989
Epoetin: human recombinant erythropoietinK K Flaharty, A M Grimm, P H Vlasses
Pharmacotherapy|January 1, 1989
Angiotensin-converting enzyme inhibitors: mechanistic controversiesM R Ujhelyi, R K Ferguson, P H Vlasses
Clinical Pharmacology and Therapeutics|March 1, 1990
Influence of single and multiple doses of oral ranitidine on the gastric transit of an indigestible capsule in humansP Mojaverian, P H Vlasses, S Parker, et al.
The Annals of Pharmacotherapy|December 1, 1996
Anticoagulant therapy monitoring with international normalized ratio at US academic health centersJ M Yim, G W Albers, P H Vlasses
Comprehensive Therapy|November 1, 1982
Common pitfalls in the treatment of hypertensionH H Rotmensch, P H Vlasses, R K Ferguson
Pharmacotherapy|March 1, 1983
Resolution of captopril-induced rash after substitution of enalaprilH H Rotmensch, P H Vlasses, R K Ferguson
American Heart Journal|May 1, 1985
Clinical pharmacology and therapeutic applications of the new oral converting enzyme inhibitor, enalaprilL J Riley, P H Vlasses, R K Ferguson
Journal of Clinical Pharmacology|January 1, 1985
Academic-industrial clinical pharmacology: a working modelR K Ferguson, P H Vlasses, W B Abrams
Pageof 17

Showing results (41-50 of 169) with videos related to

Sort By:
Pageof 17
Rational Drug Therapy|August 1, 1984
Amiodarone: a new drug for the treatment of cardiac arrhythmiasA J Greenspon, P H Vlasses, R K Ferguson
Clinical Nephrology|October 1, 1984
Creatinine serum concentrations and H2-receptor antagonistsM L Rocci, P H Vlasses, R K Ferguson
Clinical Pharmacy|November 1, 1989
Epoetin: human recombinant erythropoietinK K Flaharty, A M Grimm, P H Vlasses
Pharmacotherapy|January 1, 1989
Angiotensin-converting enzyme inhibitors: mechanistic controversiesM R Ujhelyi, R K Ferguson, P H Vlasses
Clinical Pharmacology and Therapeutics|March 1, 1990
Influence of single and multiple doses of oral ranitidine on the gastric transit of an indigestible capsule in humansP Mojaverian, P H Vlasses, S Parker, et al.
The Annals of Pharmacotherapy|December 1, 1996
Anticoagulant therapy monitoring with international normalized ratio at US academic health centersJ M Yim, G W Albers, P H Vlasses
Comprehensive Therapy|November 1, 1982
Common pitfalls in the treatment of hypertensionH H Rotmensch, P H Vlasses, R K Ferguson
Pharmacotherapy|March 1, 1983
Resolution of captopril-induced rash after substitution of enalaprilH H Rotmensch, P H Vlasses, R K Ferguson
American Heart Journal|May 1, 1985
Clinical pharmacology and therapeutic applications of the new oral converting enzyme inhibitor, enalaprilL J Riley, P H Vlasses, R K Ferguson
Journal of Clinical Pharmacology|January 1, 1985
Academic-industrial clinical pharmacology: a working modelR K Ferguson, P H Vlasses, W B Abrams
Pageof 17